GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moogene Medi Co Ltd (XKRX:322970) » Definitions » Interest Coverage

Moogene Medi Co (XKRX:322970) Interest Coverage : 0 (At Loss) (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Moogene Medi Co Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Moogene Medi Co's Operating Income for the six months ended in . 20 was ₩0.00 Mil. Moogene Medi Co's Interest Expense for the six months ended in . 20 was ₩0.00 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Moogene Medi Co's Interest Coverage or its related term are showing as below:


XKRX:322970's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 119.89
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Moogene Medi Co Interest Coverage Historical Data

The historical data trend for Moogene Medi Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Moogene Medi Co Interest Coverage Chart

Moogene Medi Co Annual Data
Trend
Interest Coverage

Moogene Medi Co Semi-Annual Data
Interest Coverage

Competitive Comparison of Moogene Medi Co's Interest Coverage

For the Biotechnology subindustry, Moogene Medi Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moogene Medi Co's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moogene Medi Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Moogene Medi Co's Interest Coverage falls into.


;
;

Moogene Medi Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Moogene Medi Co's Interest Coverage for the fiscal year that ended in . 20 is calculated as

Here, for the fiscal year that ended in . 20, Moogene Medi Co's Interest Expense was ₩0.00 Mil. Its Operating Income was ₩0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was ₩0.00 Mil.

Moogene Medi Co had no debt (1).

Moogene Medi Co's Interest Coverage for the quarter that ended in . 20 is calculated as

Here, for the six months ended in . 20, Moogene Medi Co's Interest Expense was ₩0.00 Mil. Its Operating Income was ₩0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was ₩0.00 Mil.

Moogene Medi Co had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Moogene Medi Co  (XKRX:322970) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Moogene Medi Co Interest Coverage Related Terms

Thank you for viewing the detailed overview of Moogene Medi Co's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Moogene Medi Co Business Description

Traded in Other Exchanges
N/A
Address
670, Daewangpangyo-ro, Bundang-gu, U-space 2 A-505, Gyeonggi-do, Seongnam-si, KOR
Moogene Medi Co Ltd is a bio-technology company engaged in gene therapy and nano-materials fabrication using cutting-edge nanotechnologies. The company has developed programs to monitor KRAS-mutant cancer strains, androgenic alopecia, type two diabetes, and liver diseases.

Moogene Medi Co Headlines

No Headlines